Blog Archive January 2023| Optiscan Imaging Ltd

Home
Company
- About Us
- People
- Network
- Careers
- Sustainability
- Compliance
- FAQ
Portfolio
- Portfolio
- Technology
- Products
  - InVue
  - InForm
  - InVivage
  - ViewnVivo
  - InSpecta
- Pipeline
- Publications
- Image Gallery
- Webinars
- FAQ
Investor
News
- News
- Blog
- Events
Contact
- Contact

Sub-heading can be edited through HQI

Home > News > News

News
Blog
Events

Recent Posts

Optiscan investor webinar - December 2025
Optiscan in the news - Landmark study to use Optiscan’s imaging tech in head and neck cancer surgery
Optiscan in the news - Who’s Who with Optiscan: The next leap in real-time medical imaging
Optiscan in the news - Optiscan lifts on milestone deal with Australian Clinical Labs
Optiscan in the news - Optiscan and Australian Clinical Labs partner to accelerate digital pathology innovation

Archives

Categories

Announcements
Blogs
Blood vessel, perfusion, and barrier function
Brain cancer
Broker Research
Cell viability
Cervical assessment
Gastrointestinal assessment
General surgery
Intraoperative surgery and tumour margin delineation
Live antibody labelling
Live microflora imaging
Nano particle and drug delivery
Optiscan news
Oral cancer diagnosis and surgical margin
Proof of concept in live models
Uncategorized
Veterinary

Optiscan Imaging and Prolucid Featured in The Market Herald

Market Herald Update

31-Jan-2023 by

1

Back to All Publications

Select Category

Optiscan news
Partner news
Media

Acknowledgement of Country
Optiscan Imaging acknowledges Aboriginal and Torres Strait Islander people as the Traditional Custodians of the land on which we work and live. We offer respects to Elders past, present and emerging.

Quick Links

Follow Us

Contact Us

Stay Connected

Register Your Interest

Subscribe to Investor Alerts

Follow Us

Copyright © Optiscan Imaging Ltd

Site Map Search Terms of Use Privacy Policy Cookies Policy